About
Dr. Richard Hammer is highly trained hematopathologist/surgical pathologist with extensive experience and a focus on providing state-of-the-art diagnosis and evaluation using the latest evidence-based medicine. His lab provides high-level service in hematopathology, flow cytometry, coagulation, and molecular diagnostics in hematology. He also is involved in bioinformatics and developing tools to apply digital solutions to clinical practice and clinical decision support.
Education & Training
Medical School
Medical University of South Carolina College of Medicine
Residency
Pathology, Anatomic Pathology & Clinical Pathology
- Vanderbilt University Medical Center
Fellowship
Hematopathology
- Vanderbilt University Medical Center
Boards
Commercial Relationships and Collaborations
This faculty member or a member of his or her immediate family has a working relationship, such as providing consulting, research, or educational services, with the companies listed below. These relationships have been reported to the University of Missouri and, if appropriate, plans have been established to address potential conflicts. The following relationships were reported as of July 2020.
- Caris Lifesciences
- Roche Diagnostics
- PathEdex
Insurances
MU Health Care participates with most major managed care organizations. To find out whether MU Health Care is a participating provider in your insurance plan or network, or for information on co-payments and deductibles, please contact your insurance carrier directly.
In the News
Academic Information
Research Profile
Dr. Richard Hammer is Co-Director for the Diabetes Diagnostic Laboratory (DDL). He is currently researching several projects:
- Roche NAVIFY Tumor Board Software Clinical Impact Study
- PATHEDEX and visual heuristics
- Whole Slide Imaging and Image Analysis in Pathology Diagnosis
- Platelet granules and surface ADP receptors in Traumatic Brain Injury
- Thromboelastography in trauma and stroke
- Breast Implant associated Anaplastic Large Cell lymphoma (M.D. Anderson collaborative study)
- Bioinformatic analysis of signal pathways in cancer
- One PDL1 Dx optimization and use in lymphomas
- Geospatial Analysis of CMML and Monocytic Leukemias
Research Interests
- Leukemias and lymphomas
- Molecular diagnositics and biomarkers
- Immunohistochemical techiques
- Clinical decision support development and informatics
- Geospatial applications to clinical medicine
Areas of Expertise
- Hematopathology
- Molecular Diagnostics
- Immunohistochemistry and flow cytometery
- Clinical decision support software development